株探米国株
日本語 英語
エドガーで原本を確認する
false000104950200010495022024-11-062024-11-06

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 06, 2024

 

 

MKS INSTRUMENTS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Massachusetts

000-23621

04-2277512

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2 Tech Drive

Suite 201

 

Andover, Massachusetts

 

01810

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 978 645-5500

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, no par value

 

MKSI

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.02 Results of Operations and Financial Condition.

On November 6, 2024, MKS Instruments, Inc. announced its financial results for the quarter ended September 30, 2024. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

99.1 Press Release dated November 6, 2024

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MKS Instruments, Inc.

 

 

 

 

Date:

November 6, 2024

By:

/s/ Ramakumar Mayampurath

 

 

 

Name: Ramakumar Mayampurath
Title: Executive Vice President, Chief Financial Officer and Treasurer

 


EX-99.1 2 mksi-ex99_1.htm EX-99.1 EX-99.1

img23390321_0.jpg

EXHIBIT 99.1

 

MKS Instruments Reports Third Quarter 2024 Financial Results

 

Quarterly revenue of $896 million, at the high end of guidance
Quarterly GAAP net income of $62 million and net income per share of $0.92
Quarterly Adjusted EBITDA of $232 million and Non-GAAP net earnings per diluted share of $1.72, exceeding the high-end of guidance

Andover, MA, November 6, 2024 -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported third quarter 2024 financial results.

“MKS delivered a strong third quarter with all key financial metrics at or above the high end of our guidance ranges, demonstrating both strong execution and the value of our broad portfolio of market-leading solutions,” said John T.C. Lee, President and Chief Executive Officer. “Our unique role as an enabler of critical technology advances on the chip, wafer and substrate puts us in an excellent position as longer-term secular drivers in semiconductors and advanced electronics take hold, though the overall demand environment remains muted.”

Mr. Lee added, “Ahead of the expected market recovery, we are focused on maintaining strong profit margins and generating healthy cash flow. We are deploying our cash to manage down our debt, as shown by our most recent voluntary principal prepayment of $216 million in October, as well as fund attractive future growth opportunities in our business.”

Fourth Quarter 2024 Outlook

For the fourth quarter of 2024, the Company expects revenue of $910 million, plus or minus $40 million, Adjusted EBITDA of $226 million, plus or minus $23 million, and Non-GAAP net earnings per diluted share of $1.95, plus or minus $0.32.

Conference Call Details

A conference call with management will be held on Thursday, November 7, 2024 at 8:30 a.m. (Eastern Time). To participate in the call by phone, participants should visit the Investor Relations section of MKS’ website at investor.mks.com and click on Events & Presentations, where you will be able to register online and receive dial-in details. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. A live and archived webcast and related presentation materials will be available on the Investor Relations section of the MKS website.

 


 

About MKS Instruments

MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world's leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement, and optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.

Use of Non-GAAP Financial Results

This press release includes financial measures that are not in accordance with U.S. generally accepted accounting principles (“Non-GAAP financial measures”). These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported results under U.S. generally accepted accounting principles (“GAAP”), and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.

MKS is not providing a quantitative reconciliation of forward-looking Non-GAAP net earnings per diluted share and Adjusted EBITDA to their most directly comparable GAAP financial measures because we are unable to estimate with reasonable certainty the ultimate timing or amount of certain significant items without unreasonable efforts. These items include, but are not limited to, acquisition and integration costs, amortization of intangible assets, restructuring expense, goodwill and intangible asset impairments, excess and obsolescence inventory charges, amortization of deferred financing costs, debt refinancing fees, loss on extinguishment of debt, and the income tax effect of these items. These items are uncertain, depend on various factors, including, but not limited to, the integration of our acquisition of Atotech Limited (“Atotech”), which we acquired in August 2022 (the “Atotech Acquisition”), and the interest rate and refinancing environment, and could have a material impact on GAAP reported results for the relevant period.


For further information regarding these Non-GAAP financial measures, including a change in the fourth quarter of 2023 to the definition of Adjusted EBITDA, please refer to the tables presenting reconciliations of our Non-GAAP results to our GAAP results and the “Notes on Our Non-GAAP Financial Information” at the end of this press release.

 

Selected GAAP and Non-GAAP Financial Measures

(In millions, except per share data)

 

 

Three Months Ended

 

Nine Months Ended

 

 

Q3 2024

 

 

Q2 2024

 

 

Q3 2023

 

Q3 2024

 

 

Q3 2023

 

Net Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

Semiconductor

$

378

 

 

$

369

 

 

$

367

 

$

1,098

 

 

$

1,117

 

Electronics and Packaging

 

231

 

 

 

229

 

 

 

243

 

 

669

 

 

 

691

 

Specialty Industrial

 

287

 

 

 

289

 

 

 

322

 

 

885

 

 

 

922

 

   Total net revenues

$

896

 

 

$

887

 

 

$

932

 

$

2,652

 

 

$

2,730

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

48.2

%

 

 

47.3

%

 

 

45.7

%

 

47.8

%

 

 

45.1

%

Operating margin

 

14.3

%

 

 

14.4

%

 

 

12.6

%

 

13.7

%

 

 

(57.8

%)

Net income (loss)

$

62

 

 

$

23

 

 

$

39

 

$

99

 

 

$

(1,772

)

Diluted income (loss) per share

$

0.92

 

 

$

0.33

 

 

$

0.58

 

$

1.47

 

 

$

(26.53

)

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

48.2

%

 

 

47.3

%

 

 

47.1

%

 

47.8

%

 

 

45.6

%

Operating margin

 

21.8

%

 

 

21.7

%

 

 

21.8

%

 

21.2

%

 

 

19.3

%

Net earnings

$

116

 

 

$

103

 

 

$

98

 

$

299

 

 

$

218

 

Diluted earnings per share

$

1.72

 

 

$

1.53

 

 

$

1.46

 

$

4.42

 

 

$

3.25

 

Additional Financial Information

At September 30, 2024, the Company had $861 million in cash and cash equivalents, $3.5 billion of secured term loan principal outstanding, $1.4 billion of convertible senior notes outstanding and up to $675 million of additional borrowing capacity under a revolving credit facility, subject to certain leverage ratio requirements. During the third quarter of 2024, the Company paid a cash dividend of $15 million or $0.22 per diluted share, completed the repricing of its USD term loan B and its EUR term loan B and made a voluntary prepayment of $110 million, consisting of $69 million to its USD term loan B and €38 million to its EUR term loan B.

In October 2024, the Company made a voluntary prepayment of €200 million, which equates to $216 million, to its EUR term loan B.

 

 

 

 


SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”). These statements are only predictions based on current assumptions and expectations. Any statements that are not statements of historical fact (including statements containing the words “will,” “projects,” “intends,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” “forecasts,” “continues” and similar expressions) should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements that we make are the level and terms of our substantial indebtedness; our entry into the chemicals technology business through the Atotech Acquisition, which may expose us to significant additional liabilities; the risk that we are unable to integrate Atotech successfully or realize the anticipated synergies, cost savings and other benefits of the Atotech Acquisition; legal, reputational, financial and contractual risks resulting from the ransomware incident we identified in February 2023, and other risks related to cybersecurity, data privacy and intellectual property; competition from larger, more advanced or more established companies in our markets; the ability to successfully grow our business, including through growth of the Atotech business and growth of the Electro Scientific Industries, Inc. business, which we acquired in February 2019, and financial risks associated with those and potential future acquisitions, including goodwill and intangible asset impairments; manufacturing and sourcing risks, including those associated with limited and sole source suppliers and the impact and duration of supply chain disruptions, component shortages, and price increases; changes in global demand; the impact of a pandemic or other widespread health crisis; risks associated with doing business internationally, including geopolitical conflicts, such as the conflict in the Middle East, trade compliance, regulatory restrictions on our products, components or markets, particularly the semiconductor market, and unfavorable currency exchange and tax rate fluctuations, which risks become more significant as we grow our business internationally and in China specifically; conditions affecting the markets in which we operate, including fluctuations in capital spending in the semiconductor, electronics manufacturing and automotive industries, and fluctuations in sales to our major customers; disruptions or delays from third-party service providers upon which our operations may rely; the ability to anticipate and meet customer demand; the challenges, risks and costs involved with integrating or transitioning global operations of the companies we have acquired; risks associated with the attraction and retention of key personnel; potential fluctuations in quarterly results; dependence on new product development; rapid technological and market change; acquisition strategy; volatility of stock price; risks associated with chemical manufacturing and environmental regulation compliance; risks related to defective products; financial and legal risk management; and the other important factors described under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 and any subsequent Quarterly Reports on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise, even if subsequent events cause our views to change, after the date of this press release. Amounts reported in this press release are preliminary and subject to finalization prior to the filing of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.


###

Company Contact:

Paretosh Misra

Vice President, Investor Relations

Telephone: (978) 284-4705

Email: paretosh.misra@mksinst.com


MKS Instruments, Inc.

Unaudited Consolidated Statements of Operations

(In millions, except per share data)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

$

776

 

 

$

770

 

 

$

818

 

 

$

2,301

 

 

$

2,416

 

Services

 

120

 

 

 

117

 

 

 

114

 

 

 

351

 

 

 

314

 

Total net revenues

 

896

 

 

 

887

 

 

 

932

 

 

 

2,652

 

 

 

2,730

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

410

 

 

 

412

 

 

 

446

 

 

 

1,220

 

 

 

1,326

 

Services

 

54

 

 

 

56

 

 

 

60

 

 

 

165

 

 

 

173

 

Total cost of revenues (exclusive of amortization shown separately below)

 

464

 

 

 

468

 

 

 

506

 

 

 

1,385

 

 

 

1,499

 

Gross profit

 

432

 

 

 

419

 

 

 

426

 

 

 

1,267

 

 

 

1,231

 

Research and development

 

70

 

 

 

66

 

 

 

71

 

 

 

206

 

 

 

218

 

Selling, general and administrative

 

167

 

 

 

161

 

 

 

167

 

 

 

498

 

 

 

514

 

Acquisition and integration costs

 

3

 

 

 

2

 

 

 

3

 

 

 

6

 

 

 

14

 

Restructuring and other

 

1

 

 

 

2

 

 

 

1

 

 

 

6

 

 

 

13

 

Fees and expenses related to amendments to the Term Loan Facility

 

2

 

 

 

 

 

 

 

 

 

5

 

 

 

 

Amortization of intangible assets

 

61

 

 

 

61

 

 

 

68

 

 

 

184

 

 

 

225

 

Goodwill and intangible asset impairments

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Income (loss) from operations

 

128

 

 

 

127

 

 

 

118

 

 

 

362

 

 

 

(1,578

)

Interest income

 

(6

)

 

 

(5

)

 

 

(4

)

 

 

(17

)

 

 

(10

)

Interest expense

 

64

 

 

 

79

 

 

 

93

 

 

 

230

 

 

 

266

 

Loss on extinguishment of debt

 

5

 

 

 

38

 

 

 

 

 

 

52

 

 

 

 

Other expense (income), net

 

5

 

 

 

(7

)

 

 

7

 

 

 

(3

)

 

 

14

 

Income (loss) before income taxes

 

60

 

 

 

22

 

 

 

22

 

 

 

100

 

 

 

(1,848

)

(Benefit) provision for income taxes

 

(2

)

 

 

(1

)

 

 

(17

)

 

 

1

 

 

 

(76

)

Net income (loss)

$

62

 

 

$

23

 

 

$

39

 

 

$

99

 

 

$

(1,772

)

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.92

 

 

$

0.34

 

 

$

0.59

 

 

$

1.48

 

 

$

(26.53

)

Diluted

$

0.92

 

 

$

0.33

 

 

$

0.58

 

 

$

1.47

 

 

$

(26.53

)

Cash dividend per common share

$

0.22

 

 

$

0.22

 

 

$

0.22

 

 

$

0.66

 

 

$

0.66

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

67.4

 

 

 

67.3

 

 

 

66.9

 

 

 

67.2

 

 

 

66.8

 

Diluted

 

67.6

 

 

 

67.5

 

 

 

67.1

 

 

 

67.5

 

 

 

66.8

 

 

 


MKS Instruments, Inc.

Unaudited Consolidated Balance Sheets

(In millions)

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$

861

 

 

$

875

 

Accounts receivable, net

 

 

609

 

 

 

603

 

Inventories

 

 

940

 

 

 

991

 

Other current assets

 

 

258

 

 

227

 

Total current assets

 

 

2,668

 

 

 

2,696

 

Property, plant and equipment, net

 

 

770

 

 

 

784

 

Right-of-use assets, net

 

 

247

 

 

 

225

 

Goodwill

 

 

2,567

 

 

 

2,554

 

Intangible assets, net

 

 

2,443

 

 

 

2,619

 

Other assets

 

 

328

 

 

 

240

 

Total assets

 

$

9,023

 

 

$

9,118

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Short-term debt

 

$

50

 

 

$

93

 

Accounts payable

 

 

306

 

 

 

327

 

Other current liabilities

 

 

425

 

 

 

428

 

Total current liabilities

 

 

781

 

 

 

848

 

Long-term debt, net

 

 

4,758

 

 

 

4,696

 

Non-current deferred taxes

 

 

590

 

 

 

640

 

Non-current accrued compensation

 

 

154

 

 

 

151

 

Non-current lease liabilities

 

 

216

 

 

 

205

 

Other liabilities

 

 

126

 

 

 

106

 

Total liabilities

 

 

6,625

 

 

 

6,646

 

Stockholders' equity

 

 

 

 

 

 

Common stock

 

 

 

 

 

 

Additional paid-in capital

 

 

2,053

 

 

 

2,195

 

Retained earnings

 

 

428

 

 

 

373

 

Accumulated other comprehensive (loss) income

 

 

(83

)

 

 

(96

)

Total stockholders' equity

 

 

2,398

 

 

 

2,472

 

Total liabilities and stockholders' equity

 

$

9,023

 

 

$

9,118

 

 

 


MKS Instruments, Inc.

Unaudited Consolidated Statements of Cash Flows

(In millions)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

62

 

 

$

23

 

 

$

39

 

 

$

99

 

 

$

(1,772

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

87

 

 

 

86

 

 

 

93

 

 

 

262

 

 

 

301

 

Goodwill and intangible asset impairments

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Unrealized loss (gain) on derivatives not designated as hedging instruments

 

2

 

 

 

(3

)

 

 

3

 

 

 

2

 

 

 

23

 

Amortization of deferred financing costs and original issue discounts

 

7

 

 

 

8

 

 

 

8

 

 

 

23

 

 

 

23

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Loss on extinguishment of debt

 

5

 

 

 

38

 

 

 

 

 

 

52

 

 

 

 

Stock-based compensation

 

11

 

 

 

11

 

 

 

13

 

 

 

37

 

 

 

43

 

Provision for excess and obsolete inventory

 

16

 

 

 

14

 

 

 

24

 

 

 

41

 

 

 

54

 

Deferred income taxes

 

(72

)

 

 

(59

)

 

 

(53

)

 

 

(168

)

 

 

(173

)

Other

 

2

 

 

 

2

 

 

 

3

 

 

 

5

 

 

 

4

 

Changes in operating assets and liabilities

 

43

 

 

 

2

 

 

 

32

 

 

 

(1

)

 

 

(190

)

Net cash provided by operating activities

 

163

 

 

 

122

 

 

 

160

 

 

352

 

 

138

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from sale of long-lived assets

 

1

 

 

 

 

 

 

2

 

 

 

1

 

 

 

3

 

Purchases of property, plant and equipment

 

(22

)

 

 

(26

)

 

 

(18

)

 

 

(67

)

 

 

(53

)

Net cash used in investing activities

 

(21

)

 

 

(26

)

 

 

(16

)

 

(66

)

 

(50

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from borrowings

 

 

 

 

1,400

 

 

 

 

 

 

2,161

 

 

 

1

 

Payments of borrowings

 

(123

)

 

 

(1,269

)

 

 

(22

)

 

 

(2,198

)

 

 

(67

)

Purchase of capped calls related to Convertible Notes

 

 

 

 

(167

)

 

 

 

 

 

(167

)

 

 

 

Payments of deferred financing fees

 

 

 

 

(31

)

 

 

 

 

 

(33

)

 

 

 

Dividend payments

 

(15

)

 

 

(15

)

 

 

(15

)

 

 

(44

)

 

 

(44

)

Net payments related to employee stock awards

 

(1

)

 

 

(2

)

 

 

(1

)

 

 

(12

)

 

 

(5

)

Other financing activities

 

(5

)

 

 

(3

)

 

 

(1

)

 

 

(10

)

 

 

(1

)

Net cash used in financing activities

 

(144

)

 

 

(87

)

 

 

(39

)

 

 

(303

)

 

 

(116

)

Effect of exchange rate changes on cash and cash equivalents

 

13

 

 

 

(4

)

 

 

(3

)

 

 

3

 

 

 

(22

)

Increase (decrease) in cash and cash equivalents

 

11

 

 

 

5

 

 

102

 

 

(14

)

 

(50

)

Cash and cash equivalents at beginning of period

 

850

 

 

 

845

 

 

 

757

 

 

 

875

 

 

 

909

 

Cash and cash equivalents at end of period

$

861

 

 

$

850

 

 

$

859

 

 

$

861

 

 

$

859

 

 

 

 


The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS’ operating results:

MKS Instruments, Inc.

Schedule Reconciling Selected Non-GAAP Financial Measures

(In millions, except per share data)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income (loss)

$

62

 

 

$

23

 

 

$

39

 

 

$

99

 

 

$

(1,772

)

Acquisition and integration costs (Note 1)

 

3

 

 

 

2

 

 

 

3

 

 

 

6

 

 

 

14

 

Restructuring and other (Note 2)

 

1

 

 

 

2

 

 

 

1

 

 

 

6

 

 

 

13

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

2

 

 

 

 

 

 

 

 

 

5

 

 

 

 

Amortization of intangible assets

 

61

 

 

 

61

 

 

 

68

 

 

 

184

 

 

 

225

 

Goodwill and intangible asset impairments (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Amortization of deferred financing costs (Note 6)

 

5

 

 

 

5

 

 

 

6

 

 

 

16

 

 

 

17

 

Ransomware incident (Note 7)

 

 

 

 

 

 

 

2

 

 

 

 

 

 

14

 

Loss on extinguishment of debt (Note 8)

 

5

 

 

 

38

 

 

 

 

 

 

52

 

 

 

 

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

13

 

 

 

 

 

 

13

 

Tax effect of Non-GAAP adjustments (Note 10)

 

(23

)

 

 

(28

)

 

 

(32

)

 

 

(69

)

 

 

(131

)

Non-GAAP net earnings

$

116

 

 

$

103

 

 

$

98

 

 

$

299

 

 

$

218

 

Non-GAAP net earnings per diluted share

$

1.72

 

 

$

1.53

 

 

$

1.46

 

 

$

4.42

 

 

$

3.25

 

Weighted average diluted shares outstanding

 

67.6

 

 

 

67.5

 

 

 

67.1

 

 

 

67.5

 

 

 

66.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

163

 

 

$

122

 

 

$

160

 

 

$

352

 

 

$

138

 

Purchases of property, plant and equipment

 

(22

)

 

 

(26

)

 

 

(18

)

 

 

(67

)

 

 

(53

)

Free cash flow

$

141

 

 

$

96

 

 

$

142

 

 

$

285

 

 

$

85

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


MKS Instruments, Inc.

Schedule Reconciling Selected Non-GAAP Financial Measures

(In millions)

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2024

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Gross profit

$

432

 

 

$

419

 

 

$

426

 

 

$

1,267

 

 

$

1,231

 

GAAP gross margin

 

48.2

%

 

 

47.3

%

 

 

45.7

%

 

 

47.8

%

 

 

45.1

%

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

13

 

 

 

 

 

 

13

 

Non-GAAP gross profit

$

432

 

 

$

419

 

 

$

439

 

 

$

1,267

 

 

$

1,244

 

Non-GAAP gross margin

 

48.2

%

 

47.3

%

 

 

47.1

%

 

 

47.8

%

 

 

45.6

%

Operating expenses

$

304

 

 

$

292

 

 

$

308

 

 

$

905

 

 

$

2,809

 

Acquisition and integration costs (Note 1)

 

3

 

 

 

2

 

 

 

3

 

 

 

6

 

 

 

14

 

Restructuring and other (Note 2)

 

1

 

 

 

2

 

 

 

1

 

 

 

6

 

 

 

13

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

2

 

 

 

 

 

 

 

 

 

5

 

 

 

 

Amortization of intangible assets

 

61

 

 

 

61

 

 

 

68

 

 

 

184

 

 

 

225

 

Goodwill and intangible asset impairments (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Ransomware incident (Note 7)

 

 

 

 

 

 

 

2

 

 

 

 

 

 

14

 

Non-GAAP operating expenses

$

237

 

 

$

227

 

 

$

236

 

 

$

704

 

 

$

718

 

Income (loss) from operations

$

128

 

 

$

127

 

 

$

118

 

 

$

362

 

 

$

(1,578

)

Operating margin

 

14.3

%

 

 

14.4

%

 

 

12.6

%

 

 

13.7

%

 

 

(57.8

%)

Acquisition and integration costs (Note 1)

 

3

 

 

 

2

 

 

 

3

 

 

 

6

 

 

 

14

 

Restructuring and other (Note 2)

 

1

 

 

 

2

 

 

 

1

 

 

 

6

 

 

 

13

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

2

 

 

 

 

 

 

 

 

 

5

 

 

 

 

Amortization of intangible assets

 

61

 

 

 

61

 

 

 

68

 

 

 

184

 

 

 

225

 

Goodwill and intangible asset impairments (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Ransomware incident (Note 7)

 

 

 

 

 

 

 

2

 

 

 

 

14

 

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

13

 

 

 

 

 

 

13

 

Non-GAAP income from operations

$

195

 

 

$

192

 

 

$

203

 

 

$

563

 

 

$

526

 

Non-GAAP operating margin

 

21.8

%

 

 

21.7

%

 

 

21.8

%

 

 

21.2

%

 

 

19.3

%

Interest expense, net

$

58

 

 

$

74

 

 

$

89

 

 

$

213

 

 

$

256

 

Amortization of deferred financing costs (Note 6)

 

5

 

 

 

5

 

 

 

6

 

 

 

16

 

 

 

17

 

Non-GAAP interest expense, net

$

53

 

 

$

69

 

 

$

83

 

 

$

197

 

 

$

239

 

Net income (loss)

$

62

 

 

$

23

 

 

$

39

 

 

$

99

 

 

$

(1,772

)

Interest expense, net

 

58

 

 

 

74

 

 

 

89

 

 

 

213

 

 

 

256

 

Other expense (income), net (Note 11)

 

5

 

 

 

(7

)

 

 

7

 

 

 

(3

)

 

 

14

 

(Benefit) provision for income taxes

 

(2

)

 

 

(1

)

 

 

(17

)

 

 

1

 

 

 

(76

)

Depreciation

 

26

 

 

 

25

 

 

 

25

 

 

 

77

 

 

 

76

 

Amortization of intangible assets

 

61

 

 

 

61

 

 

 

68

 

 

 

184

 

 

 

225

 

Stock-based compensation

 

11

 

 

 

11

 

 

 

13

 

 

 

37

 

 

 

43

 

Acquisition and integration costs (Note 1)

 

3

 

 

 

2

 

 

 

3

 

 

 

6

 

 

 

14

 

Restructuring and other (Note 2)

 

1

 

 

 

2

 

 

 

1

 

 

 

6

 

 

 

13

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

2

 

 

 

 

 

 

 

 

 

5

 

 

 

 

Goodwill and intangible asset impairments (Note 4)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,827

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

(2

)

Ransomware incident (Note 7)

 

 

 

 

 

 

 

2

 

 

 

 

 

 

14

 

Loss on extinguishment of debt (Note 8)

 

5

 

 

 

38

 

 

 

 

 

 

52

 

 

 

 

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

13

 

 

 

 

 

 

13

 

Adjusted EBITDA (Note 11)

$

232

 

 

$

228

 

 

$

241

 

 

$

677

 

 

$

645

 

Adjusted EBITDA margin

 

25.9

%

 

 

25.7

%

 

 

25.8

%

 

 

25.5

%

 

 

23.6

%

 

 


MKS Instruments, Inc.

Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate

(In millions)

 

 

 

Three Months Ended September 30, 2024

 

Three Months Ended June 30, 2024

 

 

Income Before
Income Taxes

 

 

(Benefit) Provision
for Income Taxes

 

 

Effective
Tax Rate

 

Income
Before
Income Taxes

 

 

(Benefit) Provision
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

$

60

 

 

$

(2

)

 

(4.0%)

 

$

22

 

 

$

(1

)

 

(3.6%)

Acquisition and integration costs (Note 1)

 

 

3

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

Restructuring and other (Note 2)

 

 

1

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets

 

 

61

 

 

 

 

 

 

 

 

61

 

 

 

 

 

 

Amortization of deferred financing costs (Note 6)

 

 

5

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

Loss on extinguishment of debt (Note 8)

 

 

5

 

 

 

 

 

 

 

 

38

 

 

 

 

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

23

 

 

 

 

 

 

 

 

28

 

 

 

Non-GAAP

 

$

137

 

 

$

21

 

 

15.1%

 

$

130

 

 

$

27

 

 

20.5%

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2023

 

 

 

 

 

 

 

 

Income Before
Income Taxes

 

 

(Benefit) Provision
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

 

 

 

 

 

 

$

22

 

 

$

(17

)

 

(75.3%)

Acquisition and integration costs (Note 1)

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

Restructuring and other (Note 2)

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

Amortization of intangible assets

 

 

 

 

 

 

 

 

68

 

 

 

 

 

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

Amortization of deferred financing costs (Note 6)

 

 

 

 

 

 

 

 

6

 

 

 

 

 

 

Ransomware incident (Note 7)

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

 

13

 

 

 

 

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

 

 

 

 

 

 

32

 

 

 

Non-GAAP

 

 

 

 

 

 

 

$

114

 

 

$

16

 

 

14.2%

 

 

 

Nine Months Ended September 30, 2024

 

Nine Months Ended September 30, 2023

 

 

Income Before
Income Taxes

 

 

Provision
for Income Taxes

 

 

Effective
Tax Rate

 

(Loss) Income Before
Income Taxes

 

 

(Benefit) Provision
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

$

100

 

 

$

1

 

 

1.2%

 

$

(1,848

)

 

$

(76

)

 

4.1%

Acquisition and integration costs (Note 1)

 

 

6

 

 

 

 

 

 

 

 

14

 

 

 

 

 

 

Restructuring and other (Note 2)

 

 

6

 

 

 

 

 

 

 

 

13

 

 

 

 

 

 

Fees and expenses related to amendments to the Term Loan Facility (Note 3)

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets

 

 

184

 

 

 

 

 

 

 

 

225

 

 

 

 

 

 

Goodwill and intangible asset impairments (Note 4)

 

 

 

 

 

 

 

 

 

 

1,827

 

 

 

 

 

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

 

 

(2

)

 

 

 

 

 

Amortization of deferred financing costs (Note 6)

 

 

16

 

 

 

 

 

 

 

 

17

 

 

 

 

 

 

Ransomware incident (Note 7)

 

 

 

 

 

 

 

 

 

 

14

 

 

 

 

 

 

Loss on extinguishment of debt (Note 8)

 

 

52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Excess and obsolete charge from discontinued product line (Note 9)

 

 

 

 

 

 

 

 

 

 

13

 

 

 

 

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

69

 

 

 

 

 

 

 

 

131

 

 

 

Non-GAAP

 

$

369

 

 

$

70

 

 

19.3%

 

$

273

 

 

$

55

 

 

20.1%

 


MKS Instruments, Inc.
Notes on Our Non-GAAP Financial Information

Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported GAAP results, and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

 

Note 1: Acquisition and integration costs related to the Atotech Acquisition.

Note 2: Restructuring and other costs primarily related to severance costs due to global cost-saving initiatives.

Note 3: During the three and nine months ended September 30, 2024, we recorded fees and expenses related to an amendment to our term loan facility where we refinanced our existing USD term loan B and EUR term loan B. During the nine months ended September 30, 2024, we recorded fees and expenses related to an amendment to our term loan facility where we borrowed additional amounts under our USD term loan B and EUR term loan B and fully paid our term loan A.

Note 4: During the nine months ended September 30, 2023, we noted softer industry demand, particularly in the personal computer and smartphone markets and concluded there was a triggering event at our Materials Solutions Division, which represents the former Atotech business, and Equipment Solutions Business, which represents the former Electro Scientific Industries business and is a reporting unit of our Photonics Solutions Division. We performed a quantitative assessment which resulted in an impairment of $1.3 billion for our Materials Solutions Division and $0.5 billion for our Equipment Solutions Business.

Note 5: We recorded a gain on the sale of a minority interest investment in a private company.

Note 6: We recorded additional interest expense related to the amortization of deferred financing costs associated with our term loan facility.

Note 7: We recorded costs, net of recoveries, associated with the ransomware incident we identified on February 3, 2023. These costs were primarily comprised of various third-party consulting services, including forensic experts, restoration experts, legal counsel, and other information technology and accounting professional expenses, enhancements to our cybersecurity measures, and costs to restore our systems and access our data.

Note 8: During the three and nine months ended September 30, 2024, we recorded charges to write-off deferred financing fees and original issue discount costs related to the extinguishment of debt on our USD term loan B and EUR term loan B. Additionally, during the nine months ended September 30, 2024, we recorded a charge to write-off deferred financing fees related to the extinguishment of our term loan A.

Note 9: We recorded an excess and obsolescence inventory charge related to a product line that was discontinued.

Note 10: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates.

Note 11: In the fourth quarter of 2023, we modified our definition of Adjusted EBITDA to exclude other (income) expense, net from this Non-GAAP measure. Other (income) expense, net primarily relates to changes in foreign exchange rates. We believe this change enhances investor insight into our operational performance. We have applied this modified definition of Adjusted EBITDA to all periods presented.